ArticleCureus2022
Awareness of Diabetic Retinopathy Among Diabetic Patients in King Khalid Eye Specialist Hospital, Riyadh, Saudi Arabia.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiabetic retinopathy (DR) is a leading cause of blindness. Over a third of the population with diabetes (DM) develop DR. Therefore, we aimed to investigate the awareness level of DR in the subjects with DM attending clinics at King Khaled Eye Specialist Hospital (KKESH) in Riyadh, Saudi Arabia.
methodsA cross-sectional study was carried out in KKESH. Responses from 360 subjects (men and women) with DM were collected using a validated questionnaire after obtaining informed consent. The questionnaire was constructed to assess the level of knowledge about DR, its screening, prevention, and treatment. The questionnaire responses were utilized thereafter to assess the association between the level of awareness of DR and the characteristics of the subjects. Pearson's chi-squared test was computed to exhibit the association and a p-value of <0.05 was considered significant.
resultsAlmost all the subjects answered six or more questions, thereby considered aware of DR. Only 3.6% of the subjects knew how often their eyes should be screened for DR. Only 3.2% of the subjects with DM type 1 (DM1) knew when their eyes should be examined after being diagnosed with DM. Men exhibited a significantly higher (p= 0.04) level of awareness compared to women. Comparing the other characteristics of the subjects exhibited no significant differences. In conclusion, although the studied population exhibited a good level of awareness about DR, they would benefit from further education on DR, especially on how regularly their vision is recommended to be examined to prevent DR and its consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.